dr. larkin on lenvatinib plus everolimus in patients with rcc
Published 8 years ago • 309 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
2:51
practical experience with lenvatinib/everolimus in rcc
-
3:39
managing patients on lenvatinib/everolimus in mrcc
-
2:13
dr. hutson on lenvatinib/everolimus combo in rcc
-
0:58
dr. funahashi on enhanced activity with lenvatinib/everolimus combo in rcc
-
4:05
lenvatinib increases progression free survival with everolimus in metastatic renal cell carcinoma
-
6:42
the role of lenvatinib in advanced rcc
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
4:27
lenvatinib in renal cell carcinoma
-
1:32
phase 2 trial of lenvatinib and everolimus in metastatic renal cell carcinoma
-
6:22
mtor/tki combination therapy in kidney cancer
-
1:32
three-arm trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
3:42
lenvatinib and everolimus in relapsed/refractory mrcc
-
1:31
dr. agarwal on the combination of lenvatinib and everolimus in mrcc
-
2:37
lenvatinib/everolimus in refractory mrcc
-
1:15
q-twist of lenvatinib everolimus in advanced rcc
-
5:32
lenvatinib and everolimus for advanced rcc
-
7:34
frontline sunitinib compared to everolimus in metastatic renal cell carcinoma
-
7:37
lenvatinib as up-front therapy for unresectable hcc
-
6:47
lenvatinib: new kid on the block